BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9296216)

  • 1. The role of second-look laparotomy in the long-term survival in ovarian cancer.
    Tuxen MK; Strauss G; Lund B; Hansen M
    Ann Oncol; 1997 Jul; 8(7):643-8. PubMed ID: 9296216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
    Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT
    Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced ovarian cancer patients with no evidence of disease after platinum-based chemotherapy: retrospective analysis of the role of second-look.
    Cacciari N; Zamagni C; Strocchi E; Pannuti F; Martoni A
    Eur J Gynaecol Oncol; 1999; 20(1):56-60. PubMed ID: 10422684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
    Obermair A; Sevelda P
    Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patients.
    de Gramont A; Drolet Y; Varette C; Louvet C; Gonzalez-Canall G; Krulik M; Cady J; Pigne A; Marpeau L; Barrat J
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):451-7. PubMed ID: 2702999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
    Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced ovarian cancer: long-term results following chemotherapy and second-look laparotomy.
    Davidson NG; Khanna S; Kirwan P; Bircumshaw D
    Gynecol Oncol; 1990 Dec; 39(3):295-9. PubMed ID: 2258074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma.
    Lund B; Williamson P
    Obstet Gynecol; 1990 Oct; 76(4):617-22. PubMed ID: 2216190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-look laparotomy in advanced ovarian cancer: a critical assessment of morbidity and impact on survival.
    Hempling RE; Wesolowski JA; Piver MS
    Ann Surg Oncol; 1997 Jun; 4(4):349-54. PubMed ID: 9181236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic versus therapeutic second-look surgery in patients with ovarian cancer.
    Janisch H; Schieder K; Koelbl H
    Baillieres Clin Obstet Gynaecol; 1989 Mar; 3(1):191-200. PubMed ID: 2661093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma.
    Hoskins WJ; Rubin SC; Dulaney E; Chapman D; Almadrones L; Saigo P; Markman M; Hakes T; Reichman B; Jones WB
    Gynecol Oncol; 1989 Sep; 34(3):365-71. PubMed ID: 2548935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy. The Gruppo Oncologico Nord Ovest.
    Chiara S; Lionetto R; Campora E; Oliva C; Merlini L; Bruzzi P; Rosso R; Conte PF
    Eur J Cancer; 1995; 31A(3):296-301. PubMed ID: 7786592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of second-look laparotomy in the management of patients with ovarian epithelial malignancies.
    Podczaski ES; Stevens CW; Manetta A; Whitney CW; Larson JE; Mortel R
    Gynecol Oncol; 1987 Oct; 28(2):205-14. PubMed ID: 3666578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
    Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
    J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration.
    Lippman SM; Alberts DS; Slymen DJ; Weiner S; Aristizabal SA; Luditch A; Davis JR; Surwit EA
    Cancer; 1988 Jun; 61(12):2571-7. PubMed ID: 3365677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-look laparotomy after chemotherapy in the management of ovarian malignancy.
    Smirz LR; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
    Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):661-8. PubMed ID: 4040706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
    Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
    Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; GĂ©rard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy.
    Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F
    Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.